Versatile CAR T-cells for cancer immunotherapy

Fuliang Chu; Jingjing Cao; Sattva S. Neelalpu

doi:10.5114/wo.2018.73892

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Bieżący numer Archiwum Współczesna Onkologia

NOWOŚĆ

Portal dla onkologów!

www.eonkologia.pl

Wyszukiwanie

1/2018

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Artykuł przeglądowy

Versatile CAR T-cells for cancer immunotherapy

Fuliang Chu

,

Jingjing Cao

,

Sattva S. Neelalpu

DOI: https://doi.org/10.5114/wo.2018.73892

Data publikacji online: 2018/03/08

Pełna treść artykułu Pobierz cytowanie

Metryki PlumX:

Chimeric antigen receptor (CAR) T-cell therapy has been clinically proven to efficiently combat haematological malignancies. However, continuous efforts are required to increase the specificity of CAR T-cells against tumour versus normal tissues, and are essential to improve their antitumour activity in solid tumours. This review summarises the structure of major CAR designs, and strategies to overcome immunosuppressive tumour microenvironment, and reduce toxicities. Along with reviewing currently available techniques that allow the elimination of CAR T-cells after they fulfil their desired functions, using suicide genes, drug elimination strategies are also introduced. A better understanding of the strengths and pitfalls of CAR T-cell therapy will provide fundamental knowledge for the improvement of engineered T-cell therapy in the near future.

Versatile CAR T-cells for cancer immunotherapy

Fuliang Chu , Jingjing Cao , Sattva S. Neelalpu

Fuliang Chu

,

Jingjing Cao

,

Sattva S. Neelalpu